NasdaqGS - Delayed Quote • USD
HilleVax, Inc. (HLVX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.84 | -0.87 | -3.02 | -3.52 |
| Low Estimate | -0.89 | -0.99 | -3.4 | -4.01 |
| High Estimate | -0.81 | -0.8 | -2.62 | -2.83 |
| Year Ago EPS | -0.71 | -0.74 | -3.04 | -3.02 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.94 | -0.9 | -0.84 | -0.83 |
| EPS Actual | -0.71 | -0.74 | -0.81 | -0.78 |
| Difference | 0.23 | 0.16 | 0.03 | 0.05 |
| Surprise % | 24.50% | 17.80% | 3.60% | 6.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.84 | -0.87 | -3.02 | -3.52 |
| 7 Days Ago | -0.84 | -0.87 | -3.02 | -3.52 |
| 30 Days Ago | -0.85 | -0.9 | -3.1 | -3.51 |
| 60 Days Ago | -0.84 | -0.9 | -3.24 | -3.5 |
| 90 Days Ago | -0.84 | -0.9 | -3.24 | -3.5 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | HLVX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -18.30% | -- | -- | 6.50% |
| Next Qtr. | -17.60% | -- | -- | 12.00% |
| Current Year | 0.70% | -- | -- | 5.30% |
| Next Year | -16.60% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/21/2024 |
| Initiated | HC Wainwright & Co.: Buy | 12/13/2023 |
| Maintains | Guggenheim: Buy to Buy | 11/15/2023 |
| Maintains | Stifel: Buy to Buy | 11/10/2023 |
| Maintains | JP Morgan: Overweight to Overweight | 5/16/2023 |
| Initiated | Guggenheim: Buy | 5/24/2022 |
Related Tickers
ANRO Alto Neuroscience, Inc.
14.18
+0.35%
VALN Valneva SE
7.64
+1.32%
TYRA Tyra Biosciences, Inc.
15.67
+3.71%
LXEO Lexeo Therapeutics, Inc.
12.50
+2.80%
AVTE Aerovate Therapeutics, Inc.
21.75
+0.83%
THRD Third Harmonic Bio, Inc.
10.83
+3.54%
688428.SS InnoCare Pharma Limited
8.32
+2.21%
NB11.F Vaxart, Inc.
0.6335
-3.06%
NGNE Neurogene Inc.
29.96
+0.30%
ANAB AnaptysBio, Inc.
21.00
+11.29%